PPT-Measles M orbilli, Rubeola, or red Measles

D Amani Elgadal D efinition Measles is a highly contagious viral infection It is exanthematous disease with fever cough coryza rhinitis and conjunctivitis . By Jen Yu. Chicken pox and measles. Chicken Pox and Measles is caused by bodily fluids of an infected person.. Just incase you didn’t know what bodily fluids mean, it means when someone or you cough or sneeze on someone.. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . A Public Health Presentation by. Cindy . Mui. What is it?. A respiratory disease . Caused by a virus of the same name, also known as . rubeola. People who recover from measles are immune for the rest of their lives. Tenth Annual  Measles Initiative Meeting . September 13-14, 2011 Washington, DC. Sergei Deshevoi. WHO European Region . 2. Presentation outline. Regional goal and strategy. Progress towards goal. Challenges in reaching the goal in 2015. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. nd. dose and DPT Booster in 2. nd. Year of Life . Dr Pradeep Haldar. Ministry of Health & Family Welfare. Government of India. June, 2016. Universal Immunization Programme . (Scope and scale). WHO Western Pacific Region. UNICEF East Asia and Pacific Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 2003. : Measles elimination to be used to strengthen routine immunization . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . assessment. Dr. Satish Gupta. Measles Rubella Initiative Meeting. 18-19 September 2012. Washington DC. The India Measles SIA . India Technical advisory group on immunizations endorses the following. Delivery of second dose of measles vaccine should be via SIA in states with MCV1 coverage <80% . Accelerating progress towards measles and rubella elimination. Geneva, Switzerland 21-23 June 2016 . Jenny Rota, WHO consultant. Goal is to update information to reflect current responsibilities of the network, provide best practices, resources and guidelines. ASSO. PROF.PEDIATRICS. ICH,GOVT MEDICAL COLLEGE KOTTAYAM. LEARNING OBJECTIVES. To list essential features of clinical measles. To list 2 complications of measles. To write a treatment protocol for measles. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. Donald McLaren, MD.   . Seventh International Symposium in Continuing Nursing Education/March 2014. Goals of talk. To highlight measles as a still very important major cause of under 5 mortality in the developing world and discuss diagnosis, complications and treatment.